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ABSTRACT
Objective: To establish the current evidence base for
the use of orthotics and taping for people with
osteoporotic vertebral fracture (OVF).
Design: Systematic review of quantitative and
qualitative studies.
Data sources: Medline, Medline-In Process,
EMBASE, AMED, CINAHL, PEDro, TRIP, EThOS,
ProQuest Dissertations and Theses and Cochrane
(CDSR, DARE, CMR, HTA, EED) plus Cochrane Central,
UK Clinical Research Network portfolio, Controlled
Clinical Trials register and the Australian and New
Zealand Clinical Trials register.
Eligibility criteria for selecting studies: All study
designs were considered if they reported in English
and evaluated the impact of using an external support,
such as a spinal brace, orthosis or postural tape, with
adults with OVF. All outcomes were considered.
Results: Nine studies were included comprising two
parallel-group randomised controlled trials, four
randomised cross-over trials, two before-after (single
arm) studies and a parallel group observational study.
No qualitative studies were identified. A wide range of
outcomes assessing impairments, activities and
participation were assessed but the findings were
mixed. The quality of studies was limited.
Conclusions: The current evidence for using orthotic
devices or taping for people with OVF is inconsistent
and of limited quality and therefore careful
consideration should be taken by clinicians before
prescribing them in practice.
Systematic review registration number:
CRD42015020893.
INTRODUCTION
Symptomatic osteoporotic vertebral fractures
(OVF) affect 1 in 6 women and 1 in 12 men
during their lifetime.1 In Europe the annual
incidence of OVF is 10.7 and 5.7 per thou-
sand in women and men, respectively.2 In
the USA, 700 000 people are reported to
have an OVF each year,3 however, these
ﬁgures may underestimate the actual size of
the problem as most OVF go unreported
and, therefore, undiagnosed.4 With the
prevalence of osteoporosis predicted to
increase by 2021, a rise in associated frac-
tures is also likely.5
OVF have personal, societal and economic
costs.6 Patients experience severe pain in the
acute phase but also up to 2 years post-
fracture.1 7 Increased disability and depres-
sion, and a reduced quality of life are also
reported.8 Up to a ﬁfth will suffer a subse-
quent vertebral fracture within a year9 and
there is an increased risk of mortality.10 The
use of primary care services has been found
to be 14 times that of the general popula-
tion,11 with 8% of people with OVF requiring
hospitalisation.12 In the USA, the manage-
ment OVF has an annual estimated cost of
$13.8 billion.1
Guidelines for the non-medical and non-
surgical management of OVF are conﬂicting.
The American Academy of Orthopaedic
Surgeons (AAOS)13 report inconclusive evi-
dence in relation to rehabilitative interven-
tions whereas the Scottish Intercollegiate
Guidelines Network (SIGN)14 recommend
electrical ﬁeld therapy and supervised exer-
cise programmes. There are a variety of
external support devices available including
rigid thoracolumbar spinal orthoses (TLSO)
or hyperextension braces that are often used
in the management of OVF, however, they
are not recommended in current guide-
lines.13 Bracing is reported to assist healing
when worn for up to 3 months but when
Strengths and limitations of this study
▪ The review comprised a broad search strategy,
including grey literature, to maximise the capture
of all of the relevant literature.
▪ No qualitative studies have been undertaken to
establish the experiences of using people with
osteoporotic vertebral fractures using orthotics
or braces.
▪ The included studies were generally of unclear
risk of bias using the Cochrane tool.
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worn for an extended period can result in muscle
atrophy, postural muscle weakness15 and skin pro-
blems.16 This said, these devices are used by the people
with OVF and clinicians continue to prescribe them,
although practice varies.
In view of recently published studies, this review aimed
to identify and update the current evidence base for the
use of orthotics and taping for people with OVF.
METHODS
We used the preferred reporting items for systematic
reviews and meta-analyses (PRISMA) as a guideline for
reporting this study. A predeﬁned protocol was regis-
tered with PROSPERO (CRD 42015020893).
Identification and selection of studies
We included primary studies that used quantitative or
qualitative methods evaluating the impact of using an
external support, such as a spinal brace, orthosis or pos-
tural tape, with adults with OVF. We were interested in
outcomes relating to the WHO International
Classiﬁcation of Functioning, Disability and Health
(ICF) domains of body structure and function, activities
and participation. We were also interested in the experi-
ences and perceptions of users of the external support.
We excluded studies that involved traumatic vertebral
fractures, non-vertebral fractures and those involving
children, reviews and opinion papers, studies published
only as an abstract and those where full text was not
available in English. We also excluded controlled studies
where the intervention also included surgical, pharma-
cological and rehabilitation interventions, except where
these were provided to intervention and comparator par-
ticipants. For non-controlled studies, only those where
the evaluation related to the orthotic device/tape were
included.
The search strategy (see online supplementary ﬁle)
was applied from 1980 to April 2015 to Medline,
Medline-In Process, EMBASE, AMED, CINAHL, PEDro,
TRIP, EThOS, ProQuest Dissertations and Theses and
Cochrane (CDSR, DARE, CMR, HTA, EED). In addition
we searched clinical trials databases, including Cochrane
Central, UK Clinical Research Network portfolio,
Controlled Clinical Trials register and the Australian and
New Zealand Clinical Trials register. We also undertook
forward and backward citation checking.
The search and screening process was managed using
Endnote. Two reviewers independently screened titles
and abstracts. Full-text papers were then screened
against the eligibility criteria independently by two
reviewers. Discrepancies were discussed and agreed.
Assessment of study characteristics
Data were extracted using a prepiloted form by one
reviewer and checked by a second. The data included
study characteristics (study design, selection criteria,
setting and sample size), funding sources, ethical
approval, population (age, gender, time since OVF),
intervention and comparator characteristics (nature of
intervention, duration of wear, concomitant interven-
tions and adherence), outcomes, time points of
follow-up and ﬁndings.
Study quality was assessed using the Cochrane Risk of
Bias tool17 and was extracted by one reviewer and
checked by a second. The data included random
sequence generation, allocation concealment, blinding
of participants and personnel, blinding of outcome
assessment, incomplete outcome data, selective report-
ing and other sources of bias. Each item was rated as low
risk, high risk or unclear risk of bias and reported for
individual studies and across the studies.
Data synthesis
A narrative approach was used to synthesise the study
ﬁndings due to methodological (study design, outcomes)
and clinical (participant and intervention character-
istics) heterogeneity. This approach enabled exploration
of relationships within the data.18 Risk of bias was sum-
marised for individual studies and across studies.
RESULTS
Our initial search resulted in 667 citations (ﬁgure 1) of
which 84 were assessed against the selection criteria; the
remainder did not meet the inclusion criteria. Nine
studies were included in this review
Characteristics of studies
The studies included 468 participants of which 404
(86%) were women. Where reported, participants had a
mean (SD) age of 72.1 (7.9) years and had sustained an
OVF between 3 days and 2 years previously. Six studies
did not report time since fracture. The number of parti-
cipants in each study varied from 13 to 108 (Mean=52).
Studies took place in Europe,19–22 Asia23–26 and
Australia.27 The majority of participants were ambulatory
and community-dwelling. One study was undertaken
with inpatients.25 Most studies took place in an out-
patient setting with the setting being unclear in one
study.26
Eight studies evaluated six different orthotic devices
including rigid supports (TLSO, 3 point orthosis, plaster
corset); semi-rigid supports (Spinomed and Spinomed
Active); and ﬂexible supports (soft brace) and one
examined the effect of postural taping. Four studies eval-
uated two different types of orthotics. Controls included
no brace, an alternative orthotic device (soft brace) or
placebo (hypoallergenic tape). The devices were worn
for between 15 min and 24 h a day (table 1). Adherence
to wearing the orthotics was assessed by self-report in
three studies21 22 26 although adherence was not
deﬁned. Additional data regarding individual study
characteristics are reported in table 1.
Two parallel-group randomised controlled trials,25 26
four randomised cross-over trials,21 22 24 27 two
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before-after (single arm) studies19 23 and a parallel
group observational study20 were included. Three
studies had three study arms.21 26 27 No qualitative
studies were identiﬁed. Of the four studies using cross-
over design, two did not report the ﬁndings from the
ﬁrst treatment period.24 27 The two studies undertaken
by Pfeifer et al21 22 reported that almost all participants
that received the intervention during the ﬁrst period
refused to stop using the device for the crossover.
Therefore, to maintain clarity when comparing the dif-
ferent intervention groups in these two studies, only the
ﬁndings from the ﬁrst period were considered in this
review.
Study quality
The results of the risk of bias assessment of study quality
are presented in ﬁgure 2 and table 2. The reporting of
studies was poor with no studies using ConSORT guide-
lines.28 Only one study reported the randomisation allo-
cation processes. None had previously registered their
studies or published a protocol. Four studies did not
report ethical approvals20 22–24 and three did not report
funding sources.20 23 27 One study was termed a ‘pilot’
although the aims were stated to determine efﬁcacy.25
Four studies undertook sample size calculations.21 22 26 27
For the four studies using a cross-over design, additional
quality assessments were made in relation to appropriate
design, randomised treatment order, carry-over effect
and unbiased data29 and these are recorded in table 2
under ‘Other’.
Effect of the intervention
The effectiveness of orthotics and taping are reported in
terms of impairments, activities and participation.
Follow-up varied from immediate,24 27 short term (<1
month),25 medium term (1–3 months)19 26 and longer
term (>3 months).20–23
Impairments
The majority of outcomes related to impairments such
as pain,19–22 25 26 postural stability,21 22 24 back
strength,19 21 22 angle of kyphosis21–23 25 27 and fracture
union.23
Pain: Two studies23 26 targeted those with acute frac-
tures using TLSO or soft brace and found no beneﬁt,
whereas those studies with those with longer term frac-
tures reported mixed ﬁndings. Pfeifer et al reported the
Spinomed device reduced pain measured using Milner’s
rating scale (1=low pain to 4=very severe pain). When
compared with no brace they found an Absolute
Difference=−1.6 (95% CIs −2.1 to −1.1), with similar
ﬁndings from an earlier study.21 22 Valentin et al,19
however, did not ﬁnd improvements in pain on a 0–10
scale (with higher scores indicting worse pain) at
3 months when using Spinomed (median difference
(range)=−1 (−4.7 to 1.7); p=0.06). Li et al25 reported
that Spinomed was no better than a soft brace after
3 weeks using a 0–10 pain scale (mean pain (SD) 4.0
(2.0) vs 4.5 (2.1)).
Postural stability: A range of different methods were
used to assess postural stability such as a force plate,27
computerised dynamic posturography24 and a sway
metre.21 22 Each assessment method reported multiple
complex components of postural stability but there were
no consistent ﬁndings within or across the studies. One
cross-over study24 examined the immediate effect of the
brace or no brace on balance performance but did not
appear to consider potential carry-over effects nor
Figure 1 Flow chart of study
selection and inclusion.
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report the ﬁndings from the ﬁrst time period so it
remains unclear as to the actual effect on postural stabil-
ity of the orthosis.
Back strength: Three studies assessed the use of
Spinomed on isometric back strength.19 21 22 Pfeifer
et al21 22 reported a mean increase (SD) of 180 (152)
Newtons when wearing the device and with an absolute
difference of 182 (95% CI 125.1 to 238.9) Newtons com-
pared with wearing no brace.
Angle of kyphosis: Five studies reported angle of
kyphosis using a range of techniques, including an
inclinometer,27 radiographs23 25 and three-dimensional
photomorphometry.21 22 Postural taping was found to
have immediate improvements in thoracic kyphosis
when compared with placebo or no tape (Mean angle in
degrees (SD) 55.3 (13.5); 57.2 (13.8); and, 58.2 (12.3)
respectively; p=0.024).27 Li et al25 only assessed this
outcome on 10/51 participants and it was unclear as to
how they were selected. Two studies were unclear as to
whether the ﬁndings represented an improvement or
deterioration in kyphosis.23 25
Fracture union: Murata et al23 reported at 2 months
54.7% of participants had fracture ‘settling’; with 88.7%
settled at 6 months, however, the study did not have a
control group and was, therefore, not possible to estab-
lish what beneﬁt wearing the TLSO gave over ‘normal’
healing. The reporting of adverse events was poor with
only one study explicitly identifying them as an outcome
of interest.20 Talic et al20 found that plaster corsets
resulted in an increased risk with four patients (16%)
developing pressure sores, with no adverse events related
to using a three-point orthosis.
Activities
The impact of orthotics on activities was evaluated using
the Oswestry Disability Index (ODI),26 the Functional
Independence measure, Elderly Mobility Scale and
Modiﬁed Functional Ambulation Category,25 limitations
in everyday life21 22 and walking ability component of
the Japanese Orthopaedic Association Back Pain
Evaluation Questionnaire ( JOABPEQ).23 Pfeifer et al21 22
reported reduced disability associated with using
Table 1 Characteristics of included studies
Study design Study participants
Sample
size Intervention Comparator Follow-up
Greig et al27 Crossover RCT Community dwelling women
>50; OVF<2 years; post
menopause >5 years;
confirmed osteoporosis




Kim et al26 Parallel group RCT Age >50; acute back pain
from single OVF within 3 days
of minor trauma








No brace 12 weeks
Li et al25 Parallel group pilot
RCT
Women >55; OVF T1 to T5;
back pain due to OVF
51 Spinomed brace 3 h a
day for 2 weeks+soft
brace remainder of day
Soft brace worn all
day
2 weeks
Liaw et al24 Crossover RCT Age 65–85; confirmed OVF;
severe osteoporosis
47 Rigid TLSO No brace Immediate
Murata et al23 Before-after study Acute back pain <1 week;
confirmed OVF
55 TLSO for at least




Pfeifer et al22 Crossover RCT Ambulatory community
dwelling women >60; 1+ OVF;
kyphosis ≥60o
62 Spinomed for 2 h a day No brace 6 months
Pfeifer et al21 Crossover RCT Ambulatory community
dwelling women >60; 1+ OVF;
kyphosis ≥60o
108 1. Spinomed for 2 h a
day
2. Spinomed active for
2 hours a day
No brace 6 months
Talic et al20 Parallel group
observational study





Before-after study Women >50; receiving
treatment for osteoporosis;
confirmed OVF; back pain
>3 months
13 Spinomed worn for
15 min/day for 2 weeks;
then <2 h/day for
2 weeks; then 2–4 h/
day for 8 weeks
– 3 months
OVF, osteoporotic vertebral fracture; RCT, randomised controlled trial; TLSO, thoracolumbosacral orthosis.
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Spinomed when compared with no brace (absolute dif-
ference −2.3 (95% CI −1.7 to −2.9),21 although it is
unclear whether this is superior to a soft brace.25 Kim
et al26 found no between group differences in ODI for
those with an acute OVF when comparing TLSO (mean
difference −1.88; 95% CI −7.02 to 9.38) or soft bracing
(mean difference 2.41; −7.86 to 9.27) with no brace.
Participation
Participation, in relation to quality of life and well-being,
was evaluated in four studies.19 21 22 26 The SF36
domains were not improved by using a TLSO or soft
brace when compared with no brace (Mean Physical
component score (PCS) 32, 35 and 30 respectively;
p=0.716)26 or Spinomed (median within-group differ-
ence in Physical component score=6.5, range −9.2 to
13.3; p=0.07)19 whereas the Hobi well-being scale did
improve after wearing Spinomed (absolute differ-
ence=12.7; 95% CI 9.7 to 15.7).21 There was no indica-
tion that either outcome was moderated by population
characteristics.
DISCUSSION
This review aimed to establish the effectiveness of ortho-
tics or taping in the management of OVF. We found that
the nine included studies were of limited quality and
reported varied populations, interventions and out-
comes. For example, no studies reported whether
outcome assessors were blinded to allocation, thus the
potential for detection bias is unknown. A previous
review of the non-surgical management of OVF included
three RCTs evaluating bracing30 reported medium term
pain relief and reduced disability; however, studies were
considered to be of low/very low quality. We found little
consideration of any potential adverse events associated
with bracing or taping with this population. It has been
suggested that adherence to wearing orthotics is poor31
but despite several included studies stating adherence
data was collected it was never deﬁned and rarely
reported. In addition, there is a complete absence of
qualitative research involving this population and their
experiences of wearing these devices which would be an
essential component of any future development and
evaluation. This said, in two cross-over studies,21 22 the
fact that the participants refused to stop wearing the
orthotics at the point of crossover would suggest positive
experiences.
We found no evidence to counter the recommenda-
tions of the American Academy of Orthopaedic
Surgeons13 that indicated there was inconclusive evi-
dence to support the using of bracing in the manage-
ment of OVF, and that the quality of studies in this
clinical area remains limited. Our ﬁndings also concur
with a recent systematic review of taping that reported it
was no better than placebo or no taping in terms of
pain or disability for people with back pain.32
In terms of strengths, our study used contemporary
methods for undertaking a systematic review and regis-
tered the protocol prospectively on PROSPERO. We
searched an extensive range of databases, including grey
literature. One limitation was the exclusion of
non-English full-text papers, however, we are conﬁdent
from our extensive search (that was not restricted to
English) and screening process that any potential papers
would have failed to meet other selection criteria and
therefore would not have been included in the review. It
could also be suggested that including non-randomised
and non-controlled studies is a limitation. However, the
purpose of our review was to establish the current evi-
dence base, and not establish effectiveness, and there-
fore we considered it important to include all study
designs. In addition, the use of the risk of bias tool
enabled a judgement on the overall quality of the
Figure 2 Risk of bias graph
indicating proportion of studies
with each judgement.
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included studies, and we found that even the included
randomised controlled trials were not without
limitations.
CONCLUSIONS
There is inconclusive evidence that TLSO or soft braces
reduce pain or disability. Although the use of the
Spinomed appears to have some beneﬁt in terms of
increasing back strength and reducing disability, it does
not necessarily offer better outcomes when compared
with other devices, such as soft braces. The quality of
studies examining the effectiveness of orthotics or
taping for the management of OVF is generally limited
and therefore we would err on the side of caution when
considering their use in clinical practice. Overall, there
is limited evidence for the use of orthotics or taping
either in the acute or long-term management of those
with OVF. Further studies using high-quality methods
and reporting are required to determine whether taping
or orthotics are effective and cost-effectiveness.
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